Qi-Jing Wang

1.4k citations
26 papers · 1.1k indexed · h-index 18
Topics
Immune Cell Function and Interaction (13 papers)Immunotherapy and Immune Responses (11 papers)Cancer Immunotherapy and Biomarkers (10 papers)

In The Last Decade

Qi-Jing Wang

26 papers receiving 1.1k citations

Peers

Qi-Jing Wang
Comparison fields: 5 of 70
  • Oncology 683
  • Immunology 673
  • Molecular Biology 337
  • Pathology and Forensic Medicine 159
  • Hepatology 135
Replace Yong-Qiang Li with:
Yong-Qiang Li China
Carl C. Schimanski Germany
Li-Xi Huang China
Shi-Ping Chen China
Ilaria Marech Italy
Yagai Yang United States
Shota Fukuoka Japan
Ro Ra Oh South Korea
Pierre Combe France
Anne-Sophie Chrétien France
Qi-Jing Wang relative to Yong-Qiang Li China Yong-Qiang Li's profile →
Citations per field
00.5×1.5×
Yong-Qiang Li · 1×
Citations per year

Countries citing papers authored by Qi-Jing Wang

Since Specialization
Citations

This map shows the geographic impact of Qi-Jing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi-Jing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi-Jing Wang more than expected).

Fields of papers citing papers by Qi-Jing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi-Jing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi-Jing Wang. The network helps show where Qi-Jing Wang may publish in the future.

Co-authorship network of co-authors of Qi-Jing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qi-Jing Wang. A scholar is included among the top collaborators of Qi-Jing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi-Jing Wang. Qi-Jing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 15
2 42
3 51
4 23
5 28
6 77
7 93
8 14
9 56
10 44
11 3
12 68
13 9
14 91
15 90
16 34
17 31
18 4
19 127
20
[Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro].
2

About Qi-Jing Wang

Qi-Jing Wang is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (11 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Immunology (673 citations), Oncology (683 citations) and Hepatology (135 citations). Qi-Jing Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jian‐Chuan Xia, De-Sheng Weng, Jing-Jing Zhao, Yong-Qiang Li, Qiu-Zhong Pan, Jia He, Ke Pan, Shan-Shan Jiang, Shi-Ping Chen and Li-Xi Huang. Their work appears in journals such as PLoS ONE, Scientific Reports and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026